
VACV Envelope protein OPG108 184-192, SLSAYIIRV
Description
About VACV Envelope protein OPG108 184-192, SLSAYIIRV
The Vaccinia virus (VACV) Envelope protein OPG108 Peptide (IEDB: 59449) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Envelope protein Peptide, H-SLSAYIIRV-OH (Uniprot: P07240 aa: 184-192) from JPT is produced under strict quality control and quality management.
VACV Envelope protein OPG108 184-192, SLSAYIIRV - Specifications
- Peptide sequence: H-SLSAYIIRV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for VACV Envelope protein OPG108 184-192, SLSAYIIRV
References:
Read References with JPT’s Antigen Peptides
VACV Envelope protein OPG108 184-192, SLSAYIIRV has been described in:
Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines., Proc Natl Acad Sci U S A, 2003 (PMID: 12518065)
Impaired CD8+ T-cell reactivity against viral antigens in cancer patients with solid tumors., Infection, 2004 (PMID: 15624893)
High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera., Proteomics, 2016 (PMID: 26992070)
Documentation
Documentation for VACV Envelope protein OPG108 184-192, SLSAYIIRV
Properties
Properties of VACV Envelope protein OPG108 184-192, SLSAYIIRV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Vaccinia virus (VACV) |
Protein Name: | Envelope protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to VACV Envelope protein OPG108 184-192, SLSAYIIRV
Information | Values |
---|---|
Sequence: | H-SLSAYIIRV-OH |
Specifications: | 9mer peptide as TFA salt |